ARCpointARCPF -56.33% Days Payable is 14,413.99 as of Dec. 2025, which is 20442% above its 10-year median of 70.17. The stock has 6 warning signs investors should review. Among 190 Medical Diagnostics & Research companies, ARCpoint ranks better than 98.95% on this metric.
ARCpoint's average Accounts Payable for the
three
months ended in Dec. 2025 was $2.05 Mil. ARCpoint's Cost of Goods Sold for the
three
months ended in Dec. 2025 was $0.01 Mil.
Hence, ARCpoint's Days Payable for the
three
months ended in Dec. 2025 was 14,413.99.
The historical rank and industry rank for ARCpoint's Days Payable or its related term are showing as below:
ARCPF'
s Days Payable Range Over the Past 10 Years
Min: 39.47 Med: 70.17 Max: 7328.39
Current: 6908.7
During the past 7 years, ARCpoint's highest Days Payable was 7328.39. The lowest was 39.47. And the median was 70.17.
ARCPF's Days Payable is ranked better than 98.95% of 190
companies
in the Medical Diagnostics & Research industry
Industry Median: 67.275
vs ARCPF: 6908.70
ARCpoint's Days Payable
increased
from Dec. 2024 (825.71) to Dec. 2025 (14,413.99).
It may suggest that ARCpointdelayed paying its suppliers.
ARCpoint Days Payable Related Terms
ARCpoint Days Payable Historical Data
* Premium members only.
The historical data trend for ARCpoint's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, ARCpoint's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ARCpoint Days Payable vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, ARCpoint's Days Payable distribution charts can be found below:
* The bar in red indicates where ARCpoint's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
ARCpoint's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ARCpoint (ARCPF) has a Days Payable of 14,413.99 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on ARCpoint and its competitors. This is 20442% above median its historical median of 70.17. Over the past decade, ARCpoint's Days Payable has ranged from 39.47 to 7,328.39. According to the industry distribution chart, ARCpoint ranks #2 out of 190 companies in the Medical Diagnostics & Research industry, placing it in the top 1.1%.
Is ARCpoint's Days Payable too high?
ARCpoint's current Days Payable of 14,413.99 is 20442% above median its 10-year median of 70.17. Over the past 10 years, this metric has ranged from a low of 39.47 to a high of 7,328.39. The Medical Diagnostics & Research industry median Days Payable is 67.28. ARCpoint's value of 14,413.99 is 21325.5% above this industry median. Based on the distribution chart, ARCpoint ranks #2 out of 190 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers.
How does ARCpoint's Days Payable compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, ARCpoint ranks #2 out of 190 companies for Days Payable. This places ARCpoint in the top 1% of its industry — outperforming the majority of peers. The industry median Days Payable is 67.28. ARCpoint's value of 14,413.99 is 21325.5% above this benchmark. Historically, ARCpoint's own Days Payable has ranged from 39.47 to 7,328.39 over the past decade. While the company's 10-year median is 70.17 vs. the industry median of 67.28, ARCpoint has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Diagnostics & Research company?
The median Days Payable among Medical Diagnostics & Research companies is 67.28, based on 190 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. ARCpoint's current Days Payable of 14,413.99 is 21325.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on ARCpoint and its competitors. For the Medical Diagnostics & Research industry, the median Days Payable is 67.28 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ARCpoint's current Days Payable is 14,413.99, which is 20442% above median its own 10-year median of 70.17. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ARCpoint stock overvalued right now?
Based on GuruFocus' analysis, ARCpoint (ARCPF) is currently considered Fairly Valued. The stock's GF Value™ is $0.01, compared to a current price of $0.01 — trading right at its estimated fair value. The current Days Payable is 14,413.99, which is 20442% above median its 10-year median of 70.17 and 21325.5% above the Medical Diagnostics & Research industry median of 67.28. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For ARCpoint (ARCPF), the current Days Payable is 14,413.99 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
ARCpoint Inc is a U.S-based franchise system providing drug testing, alcohol screening, DNA and clinical lab testing, corporate wellness programs, and employment and background screening, among other services. The platform also digitalizes and streamlines administrative functions such as materials purchasing, compliance, billing, and physician services for ARCpoint franchise labs and other clients.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ARCPF has been successfully added to your 